ACE inhibitörü: Anjiyotensin dönüştürücü enzim inhibitörü

AFCAPS: Air Force Coronary Atherosclerosis Prevention Study

ALLHAT: Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial

ARB: Anjiyotensin II Reseptör Blokeri

BKİ: Beden Kitle İndeksi

CARE: Cholesterol And Recurrent Events

EKG: Elektrokardiyografi

HDL-K: Yüksek yoğunluklu lipoprotein-kolesterol

HOPE: Heart Outcomes Prevention Evaluation study

IDNT: Irbesartan Diabetic Nephropathy Trial

IRMA: IRbesartan in type 2 diabetes with MicroAlbuminuria

LDL-K: Düşük yoğunluklu lipoprotein-kolesterol

LIFE: Losartan Intervention For Endpoint reduction in hypertension

LIPID: Long-term Intervention with Pravastatin in Ischemic Disease

MİCRO-HOPE: MIcroalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation

NCEP (ATP III): National Cholesterol Education Programme

PLAC I: Pravastatin Limitation of Atherosclerosis in the Coronary arteries

PLAC II: Pravastatin Limitation of Atherosclerosis in the Coronary arteries-II

RENAAL: Reduction of Endpoint in Non-insulin-dependent diabetes mellitus with Angiotensin II Antagonist Losartan

TEKHARF: Türk Erişkinlerinde Kalp Hastalığı ve Risk Faktörleri çalışması

TexCAPS: Texas Coronary Atherosclerosis Prevention Study

TK: Total kolesterol

TKD: Türk Kardiyoloji Derneği

VLDL: Çok düşük yoğunluklu lipoprotein

WOSCOPS: West Of Scotland COronary Prevention Study